User profiles for Gestur Vidarsson

Gestur Vidarsson

Professor Immunoglobulin biotherapeutics, Sanquin Research, and Dept. Pharmaceutics …
Verified email at sanquin.nl
Cited by 14715

[HTML][HTML] IgG subclasses and allotypes: from structure to effector functions

G Vidarsson, G Dekkers, T Rispens - Frontiers in immunology, 2014 - frontiersin.org
Of the five immunoglobulin isotypes, immunoglobulin G (IgG) is most abundant in human
serum. The four subclasses, IgG1, IgG2, IgG3, and IgG4, which are highly conserved, differ in …

IgA and the IgA Fc receptor

…, CA Damen, AB Van Spriel, G Vidarsson… - Trends in …, 2001 - cell.com
IgA has traditionally been regarded a non-inflammatory antibody. This might indeed be true
for secretory IgA (SIgA), which exerts its function at mucosal surfaces where commensal …

Emerging concepts in immune thrombocytopenia

…, M Rijkers, J Voorberg, G Vidarsson… - Frontiers in …, 2018 - frontiersin.org
Immune thrombocytopenia (ITP) is an autoimmune disease defined by low platelet counts
which presents with an increased bleeding risk. Several genetic risk factors (eg, …

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

…, I Bontjer, NA Kootstra, WJ Wiersinga, G Vidarsson… - Science, 2020 - science.org
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
had a large impact on global health, travel, and economy. Therefore, preventative and …

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

…, M Wuhrer, C Ellen van der Schoot, G Vidarsson - Science, 2021 - science.org
INTRODUCTION Antibody function is often considered static and mostly determined by
isotype and subclass. The conserved N-linked glycan at position 297 in the Fc domain of …

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

…, HJ Bogaard, MJ van Gils, G Vidarsson… - Science translational …, 2021 - science.org
Patients diagnosed with coronavirus disease 2019 (COVID-19) become critically ill primarily
around the time of activation of the adaptive immune response. Here, we provide evidence …

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

…, O Cristianawati, S Keijzer, G Vidarsson… - The Lancet …, 2021 - thelancet.com
Background Data are scarce on immunogenicity of COVID-19 vaccines in patients with
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …

Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities

…, T Rispens, M Wuhrer, G Vidarsson - Frontiers in …, 2017 - frontiersin.org
Glycosylation of the immunoglobulin G (IgG)-Fc tail is required for binding to Fc-gamma
receptors (FcγRs) and complement-component C1q. A variety of IgG1-glycoforms is detected in …

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

…, I Jonsdottir, CE Van Der Schoot, G Vidarsson - Nature …, 2011 - nature.com
Human IgG3 displays the strongest effector functions of all IgG subclasses but has a short
half-life for unresolved reasons. Here we show that IgG3 binds to IgG-salvage receptor (FcRn), …

Macrophages eliminate circulating tumor cells after monoclonal antibody therapy

…, M Bögels, R Braster, G Vidarsson… - The Journal of …, 2014 - Am Soc Clin Investig
The use of monoclonal antibodies (mAbs) as therapeutic tools has increased dramatically in
the last decade and is now one of the mainstream strategies to treat cancer. Nonetheless, it …